Lung disease associated with amiodarone treatment
- PMID: 4054492
Lung disease associated with amiodarone treatment
Abstract
A case of pneumonitis and pulmonary fibrosis occurring during long term treatment with amiodarone hydrochloride is described. The patient, a 68 year old woman, presented with severe dyspnoea and weakness 13 months after the institution of amiodarone therapy, 200 mg. bid 6 days/week. Chest x-ray showed patchy infiltrates involving the parahilar and medullary areas of both upper lobes. The clinical symptoms and the pulmonary signs improved only after amiodarone discontinuation and steroid treatment. Radiographic abnormalities gradually cleared over 45 days except for residual lines of fibrosis in the zones of previous alveolar consolidation still present 4 months later.
Similar articles
-
Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.Circulation. 1982 Apr;65(4):819-24. doi: 10.1161/01.cir.65.4.819. Circulation. 1982. PMID: 7060263
-
[Recurrent alveolitis caused by amiodarone].G Ital Cardiol. 1986 Feb;16(2):177-80. G Ital Cardiol. 1986. PMID: 3721108 Italian.
-
[Amiodarone: a new cause of hypersensitivity pneumopathy?].Rev Pneumol Clin. 1984;40(3):205-7. Rev Pneumol Clin. 1984. PMID: 6463506 French.
-
[Diffuse interstitial pneumonitis. Possible responsibility of amiodarone. Apropos of a case and review of the literature].Poumon Coeur. 1983;39(5):263-7. Poumon Coeur. 1983. PMID: 6361718 Review. French.
-
[Amiodarone-induced segmental lung infiltration. Radiologic and computed tomographic aspects].Radiologe. 1989 Oct;29(10):519-22. Radiologe. 1989. PMID: 2682766 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical